CDT Equity, Inc. (CDT)
1.09
+0.05
(+4.81%)
USD |
NASDAQ |
Feb 13, 15:41
CDT Equity Free Cash Flow : -15.13M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| LENZ Therapeutics, Inc. | -46.16M |
| Liminatus Pharma, Inc. | -10.38M |
| Oruka Therapeutics, Inc. | -84.60M |
| Maze Therapeutics, Inc. | -108.03M |
| MapLight Therapeutics, Inc. | -109.22M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.41M |
| Cash from Investing (Quarterly) | -0.998M |
| Cash from Financing (Quarterly) | 5.997M |
| Free Cash Flow Per Share (Quarterly) | -8.142 |
| Free Cash Flow to Equity (Quarterly) | -4.212M |
| Free Cash Flow to Firm (Quarterly) | -4.356M |
| Free Cash Flow Yield | -1.21K% |